702798009: Linagliptin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Substance with enzyme inhibitor mechanism of action\Substance with hydrolase inhibitor mechanism of action\Substance with peptide hydrolase inhibitor mechanism of action\Substance with dipeptidyl peptidase IV inhibitor mechanism of action\Linagliptin

\Drug or medicament\Linagliptin

\Substance categorized by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline\Linagliptin
\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3006132016 Linagliptin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3006177019 Linagliptin en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Linagliptin	Is a	Oral hypoglycemic	false	Inferred relationship	Existential restriction modifier
Linagliptin	Is a	Substance with dipeptidyl peptidase IV inhibitor mechanism of action	true	Inferred relationship	Existential restriction modifier
Linagliptin	Has disposition	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Existential restriction modifier
Linagliptin	Is a	Chemical categorized functionally	false	Inferred relationship	Existential restriction modifier
Linagliptin	Is a	Substance with enzyme inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier
Linagliptin	Is a	Piperidine	true	Inferred relationship	Existential restriction modifier
Linagliptin	Is a	Quinazoline	true	Inferred relationship	Existential restriction modifier
Linagliptin	Is a	Drug or medicament	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing linagliptin	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Product containing precisely linagliptin 5 milligram/1 each conventional release oral tablet	Has active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Product containing empagliflozin and linagliptin	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Product containing linagliptin and metformin	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	2
Product containing linagliptin and metformin in oral dose form (medicinal product form)	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	2
Product containing precisely linagliptin 5 milligram/1 each conventional release oral tablet	Has active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier	1
Product containing precisely linagliptin 5 milligram/1 each conventional release oral tablet	Has basis of strength substance	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Product containing precisely linagliptin 5 milligram/1 each conventional release oral tablet	Has precise active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Product containing linagliptin in oral dose form (medicinal product form)	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Empagliflozin + Linagliptin	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Linagliptin	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Linagliptin + Metformin	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	2
Product containing only linagliptin and metformin in oral dose form (medicinal product form)	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	2
Product containing only linagliptin in oral dose form (medicinal product form)	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance	True	Linagliptin	Inferred relationship	Existential restriction modifier	2
Empagliflozin 25mg / Linagliptin 5mg tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 850mg tablets	Has active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 60 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (CST Pharma Ltd) 60 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets	Has active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Glyxambi 10mg/5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Glyxambi 10mg/5mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Empagliflozin 10mg / Linagliptin 5mg tablets 28 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (CST Pharma Ltd) 30 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (CST Pharma Ltd) 28 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (DE Pharmaceuticals) 60 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (DE Pharmaceuticals) 56 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (DE Pharmaceuticals) 30 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (DE Pharmaceuticals) 28 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 5mg tablets 28 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 5mg tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 850mg tablets	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 850mg tablets 56 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 5mg tablets	Has active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd)	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd)	Has active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd)	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 5mg tablets 30 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) 28 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) 30 tablet	Has specific active ingredient	True	Linagliptin	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3006132016	Linagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3006177019	Linagliptin	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module